EIT Health winners of the 2018 EIT Awards
The annual EIT Awards acknowledge exceptional achievements of members of the EIT Knowledge and Innovation Communities. The awards recognise Europe's successful start-ups, innovative projects and young entrepreneurial talent – and support their efforts. In 2018, EIT Health nominees won three of the five awards, and had five nominees among the finalists.
In 2017, projects supported by EIT Health won three of the four EIT Awards given out in 2017.
The EIT Health nominees who won the 2018 EIT Awards are:
EIT Venture Award winner for 2018
The wiinner of the EIT Venture Award, which puts the spotlight on successful entrepreneurial start-ups, was Bieke Van Gorp (foreground), Co-Founder and COO at Qompium, maker of the FibriCheck app. See the FibriCheck Success Story and video.
EIT 2018 Innovators Award winner
The EIT Innovators Award, recognising innovation teams that have developed a product or service with a high potential for societal and economic impact, went to Ioannis Tarnanas, CSO for Altoida, maker of the Alzheimer's Disease Prediction Service (ADPS). See the ADPS Success Story and video.
EIT 2018 Public Award winner
The EIT Public Award, chosen from 38 nominees by the majority of more than 8 000 online voters, was Laura Soucek, the multiple award-winning founder and CEO of Peptomyc. See the Peptomyc Success Story and video.
EIT Awards news
- EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer’s and detect stroke risk
- EIT Health nominates seven innovative people and projects for the EIT Awards
The European Health Catapult Business Plan Competition sources and accelerates 22 European start-ups in biotech, medtech and digital health. The start-ups get nine months of high-quality training as they pass through three stages: regional selection; training days and finalist’s selection; and the finals during the EIT Health Summit.
Successful applicants receive funding as smart money for business development, product validation and business plan writing. After a bootcamp and submission of a business plan the most promising projects pitch and compete for financial support and mentoring.
European Health Catapult and Bootcamp winners named at EIT Health Summit
SyNoesis, a start-up developing a cure for Parkinson’s Disease, Sleepiz, a contact-free device for home diagnosis of sleep apnea, and Aenitis, whose device improves sorting of cells in suspensions, were top winners in the three categories of the European Health Catapult pitch contest at the EIT Health Summit in Lodz, Poland on 4 December 2018. Gedea Biotech, an antibiotic-free treatment for vaginal infection, was voted the audience winner, and the top contestants from the EIT Health Bootcamp pitch competition were also chosen at the event: 1. Opsyon, 2. Smart Medical Optics and 3. WayToB.
The winners of the European Health Catapult Business Plan Competition – in the three categories of Biotech, Medtech and Digital Health – were chosen by a professional jury following pitches by 22 finalists for the EIT Health Summit audience. All participants at the Summit were allowed to vote for the fourth winner, who was granted the audience prize. The contest has become a regular highlight of the EIT Health Summit, a key annual gathering of EIT Health. The top three winners in each category received cash awards and, more importantly, the kind of recognition from the EIT Health community that can lead to further support and investment.
The European Health Catapult Business Plan Competition identifies and accelerates promising European start-ups. The 2018 competition began early this year, when a host of applicants were screened by EIT Health regional representations – the CLCs and InnoStars – and accepted into regional competitions. Following coaching, 42 regional winners went to the semifinals competitions: the Biotech contest in Leuven, Netherlands; Medtech in Grenoble, France; and Digital Health in Erlangen, Germany. They were judged based on the market readiness and anticipated impact of their healthcare innovations, and the most promising 22 start-ups were invited to compete in the finals during the 4-5 December 2018 EIT Health Summit. (Those finalists are shown in the photo above.)
This year, for the first time, the start-ups judged to be the best from EIT Health Accelerator’s Bootcamps – of which six were held in 2018 – also pitched for cash prizes and recognition at the EIT Health Summit.
Winners and runners-up, and what they do
European Health Catapult Biotech category:
- SyNoesis Therapeutics Ltd. (EIT Health InnoStars): A start-up biotech with the vision to cure Parkinson's disease (PD) and other major brain diseases has patented a new therapeutic treatment for treating PD.
- LIfT BioSciences Ltd. (EIT Health UK-Ireland): Start-up with a vision to develop the world’s first cell bank of "cancer killing neutrophils" for all solid tumours has already shown 40-80% solid tumour necrosis in an FDA approved small study.
- Gedea Biotech AB (EIT Health Scandinavia): Develops a safe and antibiotic-free treatment of vaginal infections, affecting most women.
European Health Catapult Digital Health category:
- Sleepiz (EIT Health Germany): Using wireless signals, their device measures vital signs without touching the patient – enabling non-contact home diagnosis of sleep apnea.
- NeuroPsyAI (EIT Health InnoStars): Uses artificial intelligence for earlier identification of signs of neurodegenerative illnesses, such as Alzheimer’s and Parkinson’s disease, in conventional brain scans.
- FeetMe (EIT Health France): A connected insole and an associated mobile software that collects and analyses gait spatio-temporal parameters and variability. The innovation is designed to improve mobility outcomes and home rehabilitation through smart active wearable technology.
European Health Catapult Medtech category:
- Aenitis Technologies (EIT Health France): Patented medical devices for continuous, contactless and pressurless sorting of cells in suspensions, to address the challenges of cell therapy units and blood banks in cell sorting, cell washing and on cell isolation for blood, tissues and stem cells processing.
- VitaDX International (EIT Health France): Innovative medical device for early bladder cancer diagnosis combines fluorescence imaging and image processing using machine learning algorithms to detect cancerous cells in a urine sample.
- HydrUStent, LDA (EIT Health InnoStars): A biodegradable, anti-bacterial and tailor-made stent, with underlying technology protected by a patent, reduces the risk of bacterial infection and the need for surgical procedures, cutting treatment cost by 60%.
Gedea Biotech AB (EIT Health Scandinavia): Develops a safe and antibiotic-free treatment of vaginal infections, affecting most women.
Bootcamp contest winners:
- Opsyon generates new and effective immuno-oncology therapeutics with reduced systemic toxicities by combining the specificity of antibodies with the effectiveness of immune checkpoint inhibition.
- Smart Medical Optics combines optical knowledge and smart algorithms to improve the quality of malaria diagnostics in developing countries.
- WayToB provides a solution to help people with intellectual disabilities travel independently, using an app that takes instructions from carers, and keeps them in constant contact with carers.